Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
Neurosurgery. 2023 Jul 1;93(1):168-175. doi: 10.1227/neu.0000000000002396. Epub 2023 Feb 8.
Postoperative downward drift in hemoglobin (Hb) concentration may be associated with complications and death, even if nadir Hb remains more than the red blood cell transfusion threshold of 7 g/dL.
To assess whether postoperative Hb drift in patients undergoing brain tumor craniotomy influences mortality in the immediate perioperative period.
This retrospective cohort study included patients undergoing craniotomy for brain tumors. We defined no postoperative Hb decrease, mild decrease, moderate decrease, and severe decrease as postoperative Hb drift of ≤25%, 26% to 50%, 51% to 75%, and >75%, respectively. The primary outcome was 30-day mortality after craniotomy.
This study included 8159 patients who underwent a craniotomy for brain tumors. Compared with patients with no postoperative Hb drift, the odds of postoperative mortality at 30 days increased in patients with mild postoperative Hb drift (adjusted odds ratio [OR] 2.47, 95% CI 1.72-3.56), moderate drift (adjusted OR 6.56, 95% CI 3.42-12.59), and severe drift (adjusted OR 12.33, 95% CI 3.48-43.62). When postoperative Hb drift was analyzed as a continuous variable, for each 10% increase in Hb drift, the adjusted OR of postoperative mortality at 30 days was 1.46 (95% CI 1.31-1.63).
In patients undergoing brain tumor craniotomy, a small postoperative Hb drift was associated with increased odds of postoperative mortality at 30 days, even if the nadir Hb level remained greater than the red blood cell transfusion threshold of 7 g/dL. Future randomized clinical trials of perioperative transfusion practices may examine the effect of both nadir Hb and Hb drift.
血红蛋白(Hb)浓度术后下降可能与并发症和死亡有关,即使最低 Hb 仍高于红细胞输血阈值 7g/dL。
评估脑肿瘤开颅术后 Hb 术后漂移是否影响围手术期内的死亡率。
本回顾性队列研究纳入了接受脑肿瘤开颅手术的患者。我们将术后 Hb 无下降、轻度下降、中度下降和重度下降定义为术后 Hb 漂移分别为≤25%、26%至 50%、51%至 75%和>75%。主要结局是开颅术后 30 天死亡率。
本研究纳入了 8159 例行开颅术治疗脑肿瘤的患者。与术后 Hb 无漂移的患者相比,术后 30 天死亡率的术后死亡风险在术后 Hb 轻度漂移(调整后比值比[OR]2.47,95%置信区间[CI]1.72-3.56)、中度漂移(调整后 OR 6.56,95% CI 3.42-12.59)和重度漂移(调整后 OR 12.33,95% CI 3.48-43.62)的患者中增加。当术后 Hb 漂移作为连续变量进行分析时,Hb 漂移每增加 10%,术后 30 天死亡率的调整后 OR 为 1.46(95% CI 1.31-1.63)。
在接受脑肿瘤开颅术的患者中,即使最低 Hb 水平仍高于红细胞输血阈值 7g/dL,术后 Hb 轻微漂移与术后 30 天死亡率增加的几率相关。未来的围手术期输血实践的随机临床试验可能会研究最低 Hb 和 Hb 漂移的影响。